# reload+after+2024-01-21 14:40:22.939822
address1§Northern Design Centre
address2§Baltic Business Quarter
city§Gateshead
zip§NE8 3DF
country§United Kingdom
phone§44 1915 118 500
website§https://www.shieldtherapeutics.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.
fullTimeEmployees§27
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Gregory P. Madison', 'age': 55, 'title': 'CEO & Executive Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 678000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christian  Schweiger M.D., Ph.D.', 'age': 56, 'title': 'Co-Founder & Non Executive Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 45000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lucy Kate Huntington-Bailey', 'title': 'General Counsel & Company Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Suzanne  Wood', 'title': 'Group HR Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Carol  Akinola', 'title': 'Head of Pharmacovigilance & Medical Information', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Hurley', 'age': 54, 'title': 'Chief Commercial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Kate  Armanetti', 'title': 'Senior Director of People & Culture', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.172
priceToSalesTrailing12Months§7.5597925
currency§GBp
forwardEps§-1.05
exchange§LSE
quoteType§EQUITY
shortName§SHIELD THERAPEUTICS PLC ORD 1.5
longName§Shield Therapeutics plc
firstTradeDateEpochUtc§1456473600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§8d973682-42f8-3a6c-b1fe-a085c22953d5
targetHighPrice§50.0
targetLowPrice§15.0
targetMeanPrice§36.67
targetMedianPrice§45.0
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§3
quickRatio§2.642
grossMargins§0.44774
ebitdaMargins§0.0
trailingPegRatio§None
